Mo Yao

Commiphora myrrha Engl.

Also known as: Myrrh resin(English) 没药(Chinese)

Moryak沒藥 몰약 Một dược

Updated October 23, 2026 · Not yet clinically reviewed

Mo Yao
Köhler's Medizinal-Pflanzen, 1897 · public domain, via Wikimedia Commons

Safety at a glance

High risk

Pregnancy: avoid — blood-breaker — uterine-evacuating effect in an RCT

Caution

With warfarin, coumadin, anticoagulant: blood-moving herb (活血化瘀) → possible additive bleeding risk; no clinical evidence for the class

Caution

With warfarin, coumadin: reduced anticoagulant effect → INR falls (case report after an aqueous myrrh extract)

Caution

6 recorded drug interactions, 3 major or contraindicated

Note

Contraindications or side effects are listed

No rule in our tables for this herb: breastfeeding, incompatible pairs (十八反 / 十九畏), dose ceiling. This is not a safety clearance.
Not graded —

No toxicity grade is recorded. Most herbs in the catalogue carry none.

Traditional Chinese Medicine

Category
regulating blood
Temperature
Neutral
Taste
Bitter,Pungent
Channels
Heart,Liver,Spleen

Functions

Invigorates Blood and Dispels Stasis; Alleviates Pain; Reduces Swelling; Promotes Tissue Regeneration and Heals Sores

Traditional uses

Mo Yao (myrrh resin) is a neutral, bitter herb that invigorates Blood and disperses stasis to relieve pain and promote healing. It is used for pain and swelling from traumatic injuries, for menstrual pain and irregularities from Blood stagnation, and for carbuncles and sores in both the suppurating and healing stages. Applied topically, it promotes wound healing and reduces the pain of non-healing ulcers. It is frequently paired with Ru Xiang (frankincense) for enhanced Blood-moving and pain-relieving effects.

Western herbalism

Properties: analgesic, anti-inflammatory, antimicrobial, astringent, vulnerary

Formulas using this herb

32 of 32 formulas

Botanical

Commiphora myrrha (T.Nees) Engl. (Burseraceae) is a small thorny deciduous tree or large shrub 3-5 m tall native to the arid regions of the Horn of Africa and the southern Arabian Peninsula, with knotty contorted branches, peeling papery bark, and trifoliolate leaves with a larger terminal leaflet. When the bark is wounded, a pale yellow aromatic oleo-gum-resin exudes and hardens on exposure to air into reddish-brown irregular tears known as myrrh, or Mo Yao in Chinese medicine. The resin is collected, sorted, and may be processed by dry-frying or with vinegar. In TCM, Mo Yao is bitter in flavor and neutral in nature, entering the Heart, Liver, and Spleen channels; it invigorates blood, dispels stasis, alleviates pain, reduces swelling, and promotes healing of sores.

Family
Burseraceae
Pharmaceutical name
Myrrha
Parts used
resin
Plant type
tree

Constituents

Furanoeudesma-1,3-diene

Furanosesquiterpene · one of the two dominant components of the volatile oil of the oleo-gum-resin; no reliable figure for the crude drug as dispensed

The compound most often credited with myrrh's analgesic action; it was reported in 1996 to bind brain opioid receptors and to produce antinociception in mice that naloxone reversed. In LPS-stimulated RAW 264.7 macrophages it inhibits nitric oxide release with an IC50 of 46.0 microM, which is only moderate potency.

Curzerene

Furanosesquiterpene · co-dominant with furanoeudesma-1,3-diene in GC-MS profiles of Commiphora myrrha oleo-gum-resin essential oil

A furanoelemane-type rearrangement product of germacrane sesquiterpenes and a marker of genuine Commiphora myrrha resin oil. It contributes to the resin's antimicrobial and insecticidal activity; it has no established human pharmacology of its own.

29-Norlanost-8,24-dien-1alpha,3beta-diol

Triterpene · a minor isolate of the resin fraction

One of 43 compounds isolated from Commiphora myrrha resin in 2024, of which 21 were new natural products. Several of the co-isolated sesquiterpenoids reduced nitric oxide release in stimulated macrophages by up to 40 percent, a weak anti-inflammatory signal.

Water-soluble gum fraction

Polysaccharide · the bulk of the oleo-gum-resin by mass; the drug is a true oleo-gum-resin, not a pure resin

The gum is the fraction that disperses in a decoction and carries little of the sesquiterpene pharmacology. Its main practical consequence is that myrrh does not dissolve cleanly in water, which is why the classical preparations are pills and powders rather than decoctions.

Drug interactions

Warfarin

Major · Loss of anticoagulant control - the INR falls and the patient is left under-anticoagulated · Evidence level: Possible

A published case report describes a patient stabilised on warfarin whose anticoagulant effect was antagonised after taking Commiphora molmol (a myrrh species dispensed interchangeably with C. myrrha as Mo Yao). Enzyme induction with accelerated warfarin clearance is the proposed mechanism, but it was not measured. Note that the documented direction of this interaction is a LOSS of warfarin effect, not bleeding - the popular assumption that a blood-invigorating resin must add to anticoagulation is not what the single human report shows.

Clinical note: Do not add or stop myrrh in a warfarin-stabilised patient without INR monitoring. Check the INR within 3-7 days of any change and again at 2 weeks.

Boswellia species (Ru Xiang, frankincense), the routine co-prescribed pair herb

Moderate · Unpredictable additive effect on coagulation when the Ru Xiang - Mo Yao pair is given to an anticoagulated patient · Evidence level: Theoretical

Mo Yao is almost never dispensed alone; the classical pairing with Ru Xiang means the two resins are taken together in formulas such as Huo Luo Xiao Ling Dan. Boswellia resin has been reported to inhibit CYP2C9, CYP2C19 and CYP3A4 in vitro, the isoenzymes that clear warfarin, which would push the INR up, while the one human report on myrrh pushed it down. The net effect of the pair in an anticoagulated patient has never been studied and cannot be predicted from either herb alone.

Clinical note: Treat the pair as a single unquantified variable. Avoid starting it in patients on warfarin, DOACs or dual antiplatelet therapy; if it is already in the formula, do not change the dose without repeat coagulation monitoring.

Pregnancy (uterine-stimulant and abortifacient risk)

Major · Possible uterine stimulation, cramping and pregnancy loss · Evidence level: Probable

Myrrh has a real, not merely traditional, abortifacient signal. A randomised double-blind placebo-controlled trial gave 500 mg of myrrh oleo-gum-resin three times daily to 80 women with ultrasound-documented retained products of conception and achieved complete expulsion in 82.9 percent versus 54.3 percent on placebo - that is, myrrh measurably assists uterine evacuation in humans. Persian and Chinese sources independently record it as a uterine stimulant, and a case report attributes acute abdominal pain in a pregnant woman to myrrh, resolving on withdrawal.

Clinical note: Contraindicated in pregnancy at any dose and in any formula. Ask directly about pregnancy and about attempts to conceive before dispensing Mo Yao.

Praziquantel (and antischistosomal therapy generally)

Major · Untreated schistosomiasis if myrrh (marketed as Mirazid) is used in place of praziquantel · Evidence level: Established

Myrrh was commercialised in Egypt from 2001 as the antischistosomal product Mirazid on the strength of uncontrolled reports. Two randomised comparisons against praziquantel then found cure rates of 8.9-15.6 percent and 9.1 percent for myrrh against 62.5-79.7 percent for praziquantel, and most myrrh failures cleared when subsequently given praziquantel. This is a substitution hazard rather than a pharmacokinetic interaction: the harm is the parasitic disease left in place.

Clinical note: Myrrh is not an antiparasitic substitute. A patient with confirmed or suspected schistosomiasis needs praziquantel; do not let a myrrh-containing formula defer that referral.

CYP3A4 substrates (e.g. midazolam, ciclosporin, statins)

Theoretical · Unknown; possible reduced exposure to the co-administered drug if enzyme induction occurs · Evidence level: Theoretical

This entry exists to stop a cross-species inference. Guggulsterone, a potent pregnane X receptor agonist that induces CYP3A in rodent and human hepatocytes, comes from guggul, Commiphora mukul / C. wightii, an Ayurvedic drug from the same genus but not the source of Mo Yao. No comparable CYP3A data exist for Commiphora myrrha, and guggul's profile must not be transferred to it. The one clinical myrrh report (warfarin antagonism) is consistent with induction but does not identify an enzyme.

Clinical note: Do not quote guggul data as myrrh data. In practice, monitor rather than predict when myrrh is added to a narrow-therapeutic-index CYP3A4 substrate.

Adulterated or misidentified Commiphora oleo-gum-resin

Moderate · The dispensed drug may not be Commiphora myrrha at all, with unknown pharmacology · Evidence level: Possible

Commiphora oleo-gum-resins are hard to tell apart morphologically and adulteration is documented in this trade: chemical profiling of a commercial guggul (C. wightii) sample found Mangifera indica gum markers in it. The Chinese Pharmacopoeia itself admits two botanical sources for Mo Yao - Commiphora myrrha and C. molmol - sold as natural myrrh and gum myrrh, and the warfarin case report was on C. molmol, so the two are not cleanly separated in the evidence either.

Clinical note: Buy from suppliers who state the binomial and the grade (natural versus gum myrrh). Treat furanoeudesma-1,3-diene / curzerene GC-MS profiles as the authenticity check for a batch.

Dosage

FormAmountFrequencyNotes
decoction, or powder/pills3–5 gDaily
中国药典 2020 【用法与用量】3~5g,炮制去油,多入丸散用。 【注意】孕妇及胃弱者慎用。 【性味与归经】辛、苦,平。归心、肝、脾经。 — Chinese Pharmacopoeia 2020, quoted verbatim; route and cautions preserved. Replaces a cleared category-filler value.

Dui yao: classical pairings

Mo Yao + Ru Xiang乳香

Together they move blood and qi more strongly than either alone, dispersing stasis, reducing swelling and relieving pain; one leans to moving qi, the other to breaking blood stasis.

Classic for traumatic injury, painful swellings and stasis pain of the chest, abdomen and limbs; both are also core to Huo Luo Xiao Ling Dan (Zhang Xichun). Hard on the stomach; avoid in pregnancy.

Named pairing — Lü Jingshan, Shi Jinmo Dui Yao

Evidence

Study design on record, not certainty of outcome.

Randomized controlled trial
4
In vitro / animal
1

EFFICACY OF MYRRH IN THE TREATMENT OF HUMAN SCHISTOSOMIASIS MANSONI

Barakat R, Elmorshedy H, Fenwick A · The American Journal of Tropical Medicine and Hygiene · 2005 · RCT

Randomized controlled trial · Not yet verified

104 people infected with Schistosoma mansoni were randomised to myrrh (Mirazid) or praziquantel, each given twice three weeks apart. Myrrh cured 15.6 percent after the first course and 8.9 percent after the second, with egg reduction of only 17-28 percent; praziquantel cured 73.7 and 76.3 percent. Of 34 people uncured by two myrrh courses, 32 stopped passing eggs after praziquantel. The authors concluded the antischistosomal claims for Mirazid are doubtful.

doi:10.4269/ajtmh.2005.73.365

Efficacy and safety of myrrh in patients with incomplete abortion: a randomized, double-blind, placebo-controlled clinical study

Vafaei H, Ajdari S, Hessami K, Hosseinkhani A, Foroughinia L, Asadi N, Faraji A, Abolhasanzadeh S, Bazrafshan K, Roozmeh S · BMC Complementary Medicine and Therapies · 2020 · RCT

Randomized controlled trial · Verified

80 women with ultrasound-confirmed retained products of conception received 500 mg myrrh oleo-gum-resin or placebo three times daily for two weeks. Complete abortion occurred in 82.9 percent of the myrrh group versus 54.3 percent on placebo, a significant difference. Read from a safety angle, this is direct human evidence that myrrh assists uterine evacuation, and therefore the strongest argument against giving it in a wanted pregnancy.

doi:10.1186/s12906-020-02946-z

A Pilot Study on Bioactive Constituents and Analgesic Effects of MyrLiq®, a Commiphora myrrha Extract with a High Furanodiene Content

Germano A, Occhipinti A, Barbero F, Maffei ME · BioMed Research International · 2017 · RCT

Randomized controlled trial · Verified

A small placebo-controlled pilot of a standardised high-furanodiene Commiphora myrrha extract in people with various pain syndromes reported reduced pain scores, with women responding more than men. It is a pilot with a proprietary extract, not the crude resin, and the sample is too small to establish an effect size.

doi:10.1155/2017/3804356

Clinical efficacy of new aloe vera- and myrrh-based oral mucoadhesive gels in the management of minor recurrent aphthous stomatitis: a randomized, double-blind, vehicle-controlled study

Mansour G, Ouda S, Shaker A, Abdallah HM · Journal of Oral Pathology & Medicine · 2014 · RCT

Randomized controlled trial · Verified

90 patients with minor recurrent aphthous ulcers applied a 0.5 percent aloe vera gel, a 0.5 percent myrrh gel or a plain vehicle four times daily for five days. By day 6, 76.7 percent of the myrrh group reported near-absence of pain, while aloe performed better on ulcer healing, erythema and exudation. No side effects were reported. This supports the topical, analgesic use of myrrh on mucosal sores rather than any systemic claim.

doi:10.1111/jop.12130

An Unprecedented 4,8-Cycloeudesmane, Further New Sesquiterpenoids, a Triterpene, Steroids, and a Lignan from the Resin of Commiphora myrrha and Their Anti-Inflammatory Activity In Vitro

Unterholzner A, Kuck K, Weinzierl A, Lipowicz B, Heilmann J · Molecules · 2024 · in vitro

In vitro / animal · Verified

43 compounds were isolated from Commiphora myrrha resin, 21 of them new natural products, including the first 4,8-cycloeudesmane skeleton. Eight of eleven compounds tested produced concentration-dependent but small reductions in nitric oxide release from LPS-stimulated RAW 264.7 macrophages, up to 40 percent; the reference compound furanoeudesma-1,3-diene had an IC50 of 46.0 microM, which the authors class as moderate.

doi:10.3390/molecules29184315

Safety

Contraindications

Its use is cautious in patients with weak stomach, and prohibited in pregnant women and patients without blood stasis.

Source: Xi S, Gong Y. Essentials of Chinese Materia Medica and Medical Formulas. Academic Press/Elsevier, 2017, pp. 230–235.

⚠ Rule-based cautions

These entries come from the deterministic rule tables that gate Verscienta's formula tools: classical pair prohibitions, pregnancy and lactation contraindications, dose ceilings, and drugs outside the Chinese Pharmacopoeia. The botanical-genus entries are different: advisory notes are not part of the safety screen; the Aristolochia genus check is.

Pregnancy

Avoid blood-breaker — uterine-evacuating effect in an RCT

Cultural and historical

Kai Bao Ben Cao · Northern Song dynasty

Myrrh entered the Chinese materia medica as an imported resin from Arabia and the Horn of Africa; the Song materia medica record it for traumatic injury, pain from Blood stasis, and non-healing sores, which is still the modern indication set.

Ben Cao Gang Mu · Ming dynasty

Li Shizhen groups Mo Yao with Ru Xiang (frankincense) as the standard pair for trauma medicine, noting that the two resins are used together to dispel stasis, stop pain and generate flesh. This is the textual origin of the pairing that still governs how the drug is dispensed.

References

  1. Al Faraj S. Antagonism of the anticoagulant effect of warfarin caused by the use of Commiphora molmol as a herbal medication: a case report. Annals of Tropical Medicine & Parasitology. 2005 doi:10.1179/136485905X17434
  2. Tsai HH, Lin HW, Lu YH, Chen YL, Mahady GB. A Review of Potential Harmful Interactions between Anticoagulant/Antiplatelet Agents and Chinese Herbal Medicines. PLoS ONE. 2013 doi:10.1371/journal.pone.0064255
  3. Botros S, Sayed H, El-Dusoki H, Sabry H, Rabie I, El-Ghannam M, Hassanein M, El-Wahab YA. EFFICACY OF MIRAZID IN COMPARISON WITH PRAZIQUANTEL IN EGYPTIAN SCHISTOSOMA MANSONI–INFECTED SCHOOL CHILDREN AND HOUSEHOLDS. The American Journal of Tropical Medicine and Hygiene. 2005 doi:10.4269/ajtmh.2005.72.119
  4. Latha S, Selvamani P, Prabha T. Pharmacological Uses of the Plants Belonging to the Genus Commiphora. Cardiovascular & Hematological Agents in Medicinal Chemistry. 2021 doi:10.2174/1871525718666200702125558
  5. Ahmed R, Ali Z, Wu Y, Kulkarni S, Avery MA, Choudhary MI, Khan IA. Chemical Characterization of a Commercial Commiphora wightii Resin Sample and Chemical Profiling to Assess for Authenticity. Planta Medica. 2011 doi:10.1055/s-0030-1250674
  6. Brobst DE, Ding X, Creech KL, Goodwin B, Kelley B, Staudinger JL. Guggulsterone Activates Multiple Nuclear Receptors and Induces CYP3A Gene Expression through the Pregnane X Receptor. The Journal of Pharmacology and Experimental Therapeutics. 2004 doi:10.1124/jpet.103.064329
© Verscienta Health — use subject to the API terms at https://verscienta.com/developers/api; educational reference, not medical advice